Ha WS - Search Results

1

Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells.

Kim MJ, Jung JH, Lee WS, Yun JW, Lu JN, Yi SM, Kim HJ, Chang SH, Kim GS, Hong SC, Ha WS. Kim MJ, et al. Among authors: ha ws. Oncol Rep. 2014 May;31(5):2305-11. doi: 10.3892/or.2014.3085. Epub 2014 Mar 12. Oncol Rep. 2014. PMID: 24627159

2

Tetraarsenic hexoxide demonstrates anticancer activity at least in part through suppression of NF-κB activity in SW620 human colon cancer cells.

Lee WS, Yun JW, Nagappan A, Park HS, Lu JN, Kim HJ, Chang SH, Kim DC, Lee JH, Jung JM, Hong SC, Ha WS, Kim G. Lee WS, et al. Among authors: ha ws. Oncol Rep. 2015 Jun;33(6):2940-6. doi: 10.3892/or.2015.3890. Epub 2015 Mar 31. Oncol Rep. 2015. PMID: 25845556

3

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.

Go SI, Ko GH, Lee WS, Kim RB, Lee JH, Jeong SH, Lee YJ, Hong SC, Ha WS. Go SI, et al. Among authors: ha ws. Cancer Res Treat. 2016 Jan;48(1):142-52. doi: 10.4143/crt.2014.227. Epub 2015 Mar 17. Cancer Res Treat. 2016. PMID: 25779358 Free PMC article.

4

Prognostic impact of Ki-67 in patients with gastric cancer-the importance of depth of invasion and histologic differentiation.

Ko GH, Go SI, Lee WS, Lee JH, Jeong SH, Lee YJ, Hong SC, Ha WS. Ko GH, et al. Among authors: ha ws. Medicine (Baltimore). 2017 Jun;96(25):e7181. doi: 10.1097/MD.0000000000007181. Medicine (Baltimore). 2017. PMID: 28640099 Free PMC article.

5

The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer.

Go SI, Ko GH, Lee WS, Lee JH, Jeong SH, Lee YJ, Hong SC, Ha WS. Go SI, et al. Among authors: ha ws. Cancer Res Treat. 2019 Oct;51(4):1411-1419. doi: 10.4143/crt.2018.663. Epub 2019 Feb 25. Cancer Res Treat. 2019. PMID: 30913874 Free PMC article.

6

The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer.

Jang JS, Lee WS, Lee JS, Kim HW, Ko GH, Ha WS. Jang JS, et al. Among authors: ha ws. J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S109-14. doi: 10.3346/jkms.2007.22.S.S109. J Korean Med Sci. 2007. PMID: 17923735 Free PMC article.

7

Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer.

Go SI, Ko GH, Lee WS, Lee JH, Jeong SH, Lee YJ, Hong SC, Ha WS. Go SI, et al. Among authors: ha ws. Curr Issues Mol Biol. 2022 Mar 20;44(3):1395-1406. doi: 10.3390/cimb44030093. Curr Issues Mol Biol. 2022. PMID: 35723316 Free PMC article.

8

Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.

Jeong CY, Hah YS, Cho BI, Lee SM, Joo YT, Jung EJ, Jeong SH, Lee YJ, Choi SK, Ha WS, Park ST, Hong SC. Jeong CY, et al. Among authors: ha ws. Oncol Rep. 2012 Oct;28(4):1283-92. doi: 10.3892/or.2012.1922. Epub 2012 Jul 19. Oncol Rep. 2012. PMID: 22825302

9

A phase II trial of haptaplatin/5-FU and leucovorin for advanced stomach cancer.

Lee WS, Lee GW, Kim HW, Lee OJ, Lee YJ, Ko GH, Lee JS, Jang JS, Ha WS. Lee WS, et al. Among authors: ha ws. Cancer Res Treat. 2005 Aug;37(4):208-11. doi: 10.4143/crt.2005.37.4.208. Epub 2005 Aug 31. Cancer Res Treat. 2005. PMID: 19956515 Free PMC article.

10

Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.

Jang HS, Kang KM, Choi BO, Chai GY, Hong SC, Ha WS, Jirtle RL. Jang HS, et al. Among authors: ha ws. World J Gastroenterol. 2008 Mar 7;14(9):1394-8. doi: 10.3748/wjg.14.1394. World J Gastroenterol. 2008. PMID: 18322954 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters